Research Articles

 
News Articles for Research Articles top ^
2014/7/14
HARBIN, China , July 14, 2014 /PRNewswire/ -- China XD Plastics Company Limited (NASDAQ: CXDC, "China XD Plastics" or the "Company"), one of China's leading specialty chemical players engaged in the development, manufacture and sale of polymer composite materials primarily for automotive applications, today strongly refuted the irresponsible allegations made in an article posted by Bleecker Street Research (" Bleecker Street ") on Seeking Alpha's website on July 10, 2014 (the "Bleecker Street Article"). China XD Plastics believes that the Bleecker Street Article contains numerous errors of facts, misleading speculations and malicious interpretations of events.
Sign-up for China XD Plastics Refutes Allegations in Seeking Alpha Article investment picks
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced that the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has provided the Company with a request for limited additional information regarding Iclusig ® (ponatinib) as part of its ongoing review under the Article 20 referral procedure.
Sign-up for ARIAD Announces Continuation of Iclusig Review under the Article 20 Procedure in Europe investment picks
2014/7/10
HARBIN, China , July 10, 2014 /PRNewswire/ -- China XD Plastics Company Limited (NASDAQ: CXDC, "China XD Plastics" or the "Company"), one of China's leading specialty chemical players engaged in the development, manufacture and sale of polymer composite materials primarily for automotive applications, today responded to the allegations raised by an article posted on Seeking Alpha's website dated July 10, 2014 by Bleecker Street Research.
Sign-up for China XD Plastics Responds to Seeking Alpha Article investment picks
USA Technologies, Inc. (NASDAQ: USAT), (“USAT”), a leader of wireless, cashless payment and M2M telemetry solutions for small-ticket, self-serve retailing industries, is featured in an article by PYMNTS.com today.
Sign-up for USA Technologies' Cashless Payment Service for Self-Serve Retail Businesses Featured in PYMNTS.com Article investment picks
2014/8/18
By Benjamin Pimentel, MarketWatch SAN FRANCISCO (MarketWatch) -- Purported news reports on Kim Jong Un being named "sexiest man alive" or a study that found most children are "unrepentant sociopaths" can be entertaining.
Sign-up for Facebook testing 'satire' tag for Onion-style articles investment picks
http://media.marketwire.com/attachments/201403/235782_White-Logo-Medium.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1126791&ProfileId=051205&sourceType=1 TORONTO, ON --
Sign-up for Easton Pharmaceuticals Finalizing Investment Terms in Private Medical Marijuana Device Company; Moves to Initiate Legal Action Against Libelous Seeking Alpha Article investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1130921&ProfileId=051205&sourceType=1 DENVER, CO --
Sign-up for Blue Line Protection Group Featured in 'USA Today' Article investment picks
http://media.marketwire.com/attachments/201403/235782_White-Logo-Medium.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1129583&ProfileId=051205&sourceType=1 TORONTO, ON --
Sign-up for Easton Pharmaceuticals Announces Legal Action Against Seeking Alpha Writer as a Response to Libelous Article investment picks
HERZLIYA, Israel , July 16, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd.
Sign-up for XTL Bio's hCDR1 Compound Highlighted in Article Reviewing Potential Candidates for the Treatment of Lupus Published in Journal of Autoimmunity investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Research Articles
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research ARM  |  Next: Research Assets